Tag: Ascendis Health
Pharmaceutical group Ascendis Health has released its twice delayed annual results with a reported normalised loss after tax of R459 million. The company is also looking to sell off non-core assets after its share price has come under severe pressure this year which they have attributed to impairment costs of R4.2 billion. Ascendis Health CEO, Mark Sardi joins CNBC Africa for more.
The PIC Commission of Inquiry into impropriety of investment decisions at the asset manager continues in Pretoria. The commission has been hearing from former CEO Dr Dan Matjila for 6 days. In today's hearing he was questioned on his knowledge and involvement in transactions like Ascendis Health and Mozambican oil refinery S&S Refinery. CNBC Africa’s Kopano Gumbi filed this report.
Ascendis Health, whose share price has come under severe pressure this year, recently announced plans to dispose of Afrikelp, Efekto and Marltons. Some analysts have argued it is disposing of the family silver. The health group also recently revealed a request from two shareholders for a general meeting of shareholders to be held to propose changes to the non-executive composition of the Board. Joining CNBC Africa for more is Ascendis Health CEO, Thomas Thomsen.
Ascendis Health’s share has come under severe pressure following a litany of bad news. CNBC Africa’s Kopano Gumbi spoke to one of its shareholders the Mineworkers Investment Company’s CEO Mary Bomela about what went wrong and what the black owned broad-based investment holding company investment philosophy is.